NCT00815009 Evaluation of Diet and Exercise in Patients With Non-Alcoholic Fatty Liver Disease Status COMPLETED Phase NA
NCT00799578 A Preliminary Study to Evaluate Cysteamine Therapy in Human Subjects With Non-Alcoholic Steatohepatitis (NASH) Status COMPLETED Phase PHASE1/PHASE2
NCT00742326 Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C Infections Status TERMINATED Phase PHASE4
NCT00736385 Metformin for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) Status TERMINATED Phase PHASE4
NCT00681408 Omega 3 Fish Oil Supplements vs. Placebo for Patients With Non-alcoholic Steatohepatitis (NASH) Status COMPLETED Phase PHASE2/PHASE3
NCT00585299 Effects of Weight Loss on Hepatic and Muscle Lipid Content and on Insulin Sensitivity on Obese Adolescents With NAFLD Status COMPLETED Phase NA
NCT00577148 An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients With Type 2 Diabetes Status TERMINATED Phase PHASE3
NCT00576667 An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients Without Diabetes Status TERMINATED Phase PHASE3
NCT00529204 Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease Status TERMINATED Phase PHASE2
NCT00501592 Study of INT-747 in Patients With Diabetes and Presumed NAFLD Status COMPLETED Phase PHASE2
NCT00482924 Observational Study of Early Metabolic and Vascular Changes in Obesity Status UNKNOWN Phase N/A
NCT00476879 Growth Hormone During Fasting.Signaltransduktion in Muscle and Adipose Tissue and Changes in Intrahepatic Lipid Content Status COMPLETED Phase NA
NCT00443079 A Study of Siliphos in Adults With Non-alcoholic Steatohepatitis (NASH) Status COMPLETED Phase PHASE2